retatrutide clinical trial results weight loss 2024 2025 press release 🚨Breaking: Retatrutide's first Phase 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No plateau — curve still descending Retatrutide Weight Loss Results:Trial Data

RELATED: Why Your Skin Is Changing: Inflammation, Hormones, and Cortisol Explained Highly processed foods can destabilize blood sugar and disrupt the gut environment

Is physician supervision important during medical weight loss treatment

The more compelling reason for B12 inclusion involves its potential to reduce one of the most common and most disruptive side effects of GLP-1 therapy

Advanced Hemorrhoid and Rectal Care Everyday life shouldnt be interrupted by itching, pain, or embarrassment

Our doctors emphasise that monitoring and open communication reduce risks: regular follow-up, blood tests for glucose and kidney function, and reporting worrying symptoms promptly